One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ecological governance.
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
The FDA has issued draft guidance that could speed up approval pathways for rare disease therapies using genome editing technologies. This framework is directly relevant to CRISPR Therapeutics, which ...
CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...
10d
Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
Growing Adoption of Gene Therapy Platforms, Expanding Agricultural Biotechnology Applications, and Accelerating Clinical Trial Activity Drive Robust Market Expansion.Austin, United States, Feb. 27, ...
The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are ...
CRISPR Therapeutics AG CRSP shares jumped on Thursday, building on its Feb. 13 earnings report that showed growing momentum for its lead gene therapy and a deepening pipeline. Casgevy Revenue Casgevy, ...
Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...
The past few years have been challenging for the biotech.
Gene editing has enormous potential to help feed the world’s growing population, but it’s currently difficult, time-consuming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results